Test Price
450 AEDโ Home Collection Available
Napsin A Immunohistochemistry (IHC) Test for Lung Adenocarcinoma Diagnosis in Dubai, UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval from hospital pathology archives via temperature-controlled transport.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with DHA-licensed specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Napsin A immunohistochemistry (IHC) test is a specialized diagnostic assay used to confirm primary lung adenocarcinoma by detecting the Napsin A protein in tumor tissue. It is performed on formalin-fixed paraffin-embedded (FFPE) tissue sections using automated IHC staining platforms with validated monoclonal antibodies, ensuring high specificity and sensitivity.
| Feature | Our Test (Napsin A IHC โ ISO Lab) | Closest Alternative (Standard IHC) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity with monoclonal antibody clones validated per CAP/CLIA protocols | Varied sensitivity; often uses polyclonal antibodies with manual interpretation |
| Method | Fully automated IHC staining (Ventana BenchMark ULTRA) with digital image analysis support | Manual or semi-automated IHC, may lack standardized quantification |
| Speed | Report within 5 working days (7 days for complex resections) from sample receipt | Often 7โ10 working days due to batch processing |
Physician Insight & Safety Protocols
โAs a specialist in diagnostic radiology, I emphasize that the Napsin A IHC test is a critical tool for differentiating primary lung adenocarcinoma from metastatic disease. However, it must be interpreted alongside full histopathology and clinical imaging. Our laboratory adheres to the highest standards to ensure accurate results.โ โ Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA License: 61713011
Clinical Safety Advisory
- Do not discontinue or alter any prescribed medication based solely on test results without consulting your oncologist.
- The test requires a representative tumor tissue sample; insufficient or degraded samples may lead to inconclusive results.
- Emergency symptoms such as sudden severe chest pain, acute dyspnea, or hemoptysis warrant immediate emergency careโdo not wait for test results.
Test Exclusion Criteria
- Inadequate or non-representative tumor tissue (e.g., necrotic or crushed samples).
- Patients unable to provide informed consent for tissue retrieval and testing.
- Archival blocks older than 10 years without documented quality assessment may be excluded.
Patient FAQ & Clinical Guidance
1. What is the Napsin A IHC test used for?
The Napsin A immunohistochemistry test is used to confirm a diagnosis of primary lung adenocarcinoma by detecting the Napsin A protein in tumor tissue. It helps distinguish lung adenocarcinoma from metastatic carcinomas originating from other organs.
2. How is the test performed?
The test is performed on a formalin-fixed paraffin-embedded (FFPE) tissue block or slide obtained from a biopsy or surgical resection. The tissue section is stained with a Napsin A antibody on an automated IHC platform, and the staining pattern is evaluated by a specialist pathologist.
3. What does a positive Napsin A result mean?
A positive result confirms that the tumor is primary lung adenocarcinoma and rules out metastatic carcinoma from other organs. This distinction is crucial for selecting appropriate targeted therapies and treatment plans.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Protection
This laboratory service operates under DHA Facility License No. 1143 and complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted and processed solely for diagnostic purposes.
Clinical & Logistical Metadata
| Test Name | Napsin A Immunohistochemistry (IHC) |
| Price (AED) | 450 AED |
| Turnaround Time | 5โ7 working days |
| Sample Type / Matrix | Formalin-fixed paraffin-embedded (FFPE) tumor tissue block or biopsy slides |
| Methodology Used | Automated IHC staining (Ventana BenchMark ULTRA) with digital image analysis |
| ICD-10-CM Code | C34.9 |
| LOINC Code | 94471-8 |
| DHA Facility License & Address | License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Corporate Lab: DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians